A clinical study of SYNB1020 in patients with urea cycle disorders (UCD).

Trial Profile

A clinical study of SYNB1020 in patients with urea cycle disorders (UCD).

Planning
Phase of Trial: Phase I

Latest Information Update: 27 Jun 2017

At a glance

  • Drugs SYNB 1020 (Primary)
  • Indications Inborn urea cycle disorders
  • Focus Adverse reactions
  • Most Recent Events

    • 27 Jun 2017 New trial record
    • 19 Jun 2017 According to a Synlogic media release, company plans to initiate this trial by mid-2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top